Bioinspired Oligo-Urethane Nanoparticles for Delivering Exogenous C-Type Natriuretic Peptide: Synthetic Biomaterial Nanocarrier Complexes and Their Interactions with Cardiac Myofibroblasts.


Journal

Biomacromolecules
ISSN: 1526-4602
Titre abrégé: Biomacromolecules
Pays: United States
ID NLM: 100892849

Informations de publication

Date de publication:
10 07 2023
Historique:
medline: 11 7 2023
pubmed: 22 6 2023
entrez: 21 6 2023
Statut: ppublish

Résumé

In a healthy heart, cells naturally secrete C-type natriuretic peptide (CNP), a cytokine that protects against myofibroblast differentiation of cardiac fibroblasts and extracellular matrix deposition leading to fibrosis. CNP availability during myocardial remodeling is important to prevent cardiac fibrosis, but CNP is limited after an injury because of the loss of cardiomyocytes and the activation of cardiac fibroblasts to myofibroblasts. We hypothesized that the sustained release of exogenous CNP from oligo-urethane nanoparticles (NPs) would reduce differentiation of human cardiac fibroblasts toward a myofibrogenic phenotype. Our work used a modified form of a degradable polar hydrophobic ionic (D-PHI) oligo-urethane, which has shown the ability to self-assemble into NPs for the delivery of peptide and oligonucleotide biomolecules. The CNP-loaded NPs (NP

Identifiants

pubmed: 37344353
doi: 10.1021/acs.biomac.3c00210
doi:

Substances chimiques

Transforming Growth Factor beta1 0
Natriuretic Peptide, C-Type 127869-51-6
Urethane 3IN71E75Z5

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3149-3158

Subventions

Organisme : CIHR
ID : CPG-151962
Pays : Canada

Auteurs

Nataly M Siqueira (NM)

Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario M5S 3G9, Canada.
Translational Biology and Engineering Program and Ted Rogers Centre for Heart Research, Toronto, Ontario M5G 1M1, Canada.

Shirley Chung (S)

Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario M5S 3G9, Canada.
Translational Biology and Engineering Program and Ted Rogers Centre for Heart Research, Toronto, Ontario M5G 1M1, Canada.

Suja Shrestha (S)

Translational Biology and Engineering Program and Ted Rogers Centre for Heart Research, Toronto, Ontario M5G 1M1, Canada.
Faculty of Dentistry, University of Toronto, Toronto, Ontario M5G 1G6, Canada.

Aileen Zhong (A)

Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario M5S 3G9, Canada.
Translational Biology and Engineering Program and Ted Rogers Centre for Heart Research, Toronto, Ontario M5G 1M1, Canada.

Laura-Lee Caruso (LL)

Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario M5S 3G9, Canada.
Translational Biology and Engineering Program and Ted Rogers Centre for Heart Research, Toronto, Ontario M5G 1M1, Canada.

Bahram Mirani (B)

Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario M5S 3G9, Canada.
Translational Biology and Engineering Program and Ted Rogers Centre for Heart Research, Toronto, Ontario M5G 1M1, Canada.
Department of Mechanical and Industrial Engineering, University of Toronto, Toronto M5S3G8, Canada.

Zahra Mirzaei (Z)

Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario M5S 3G9, Canada.
Translational Biology and Engineering Program and Ted Rogers Centre for Heart Research, Toronto, Ontario M5G 1M1, Canada.

Craig A Simmons (CA)

Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario M5S 3G9, Canada.
Translational Biology and Engineering Program and Ted Rogers Centre for Heart Research, Toronto, Ontario M5G 1M1, Canada.
Department of Mechanical and Industrial Engineering, University of Toronto, Toronto M5S3G8, Canada.

J Paul Santerre (JP)

Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario M5S 3G9, Canada.
Translational Biology and Engineering Program and Ted Rogers Centre for Heart Research, Toronto, Ontario M5G 1M1, Canada.
Faculty of Dentistry, University of Toronto, Toronto, Ontario M5G 1G6, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH